1 August 2018
The CataloniaBio & HealthTech website (cataloniabio.org) has received more than 96,000 visits during first half of 2018, 68% of Spain and 32% international.
Communication is a strategic focal point for the association, which has several channels aimed at members and stakeholders (investors, entrepeneurs, researchers, journalists...). These channels are the website, social media (more than 25,000 followers on Twitter and LinkedIn and 1,900 views on YouTube), the newsletter with corporate and member news (monthly), the paper review (delivered at the CataloniaBioHT Gala Dinner and BBQ) and internal communications called Weekly Bullets.
On the other hand ...
25 July 2018
Jordi Naval is the new CEO of Biocat, an organisation created in 2006 by the Government of Catalonia to promote the healthcare and life sciences ecosystem along with other actors such as ACCIÓ and the association of companies CataloniaBio & HealthTech.
He is now taking over the position that was left vacant a year ago by the previous CEO Albert Barberà, current Director General for Research and Innovation in Health.
Jordi Naval has a degree in Pharmacy from the University of Barcelona (UB) and in Biochemistry from the Autonomous University of Barcelona (UAB). He has helped launch several start-ups like ...
25 July 2018
The Research Centre for Biomedical Engineering (CREB) of the Polytechnic University of Catalonia (UPC), a CataloniaBio & HealthTech member, inaugurated its new facilities on 6 July with a day of conferences and visits from researchers and members of the UPC governing bodies.
Most of the research groups at the CREB have moved to the offices and laboratories on the fourth floor at the Barcelona School of Industrial Engineering. Previously, they were located in several different buildings at the university.
The CREB has more than 25 years of experience in technology transfer, holds 27 patents and 5 to out-license, and has ...
25 July 2018
Devicare, member of CataloniaBio & HealthTech, is moving forward in its international expansion by closing licensing and distribution agreements in Argentina, Uruguay and Peru. Various pharmaceutical companies will introduce the products from the Lit-Control® brand to improve the urinary healthcare of the residents of Latin America. The company had previously announced its entry into Mexico and Colombia.
“These agreements with leading urological pharmaceutical companies confirm our scientific work, our clinical data, as well as the commercial interest in our products” remarks Rosendo Garganta, co-Founder and CEO of the company located at the UAB Research Park.
The company expects to end ...
24 July 2018
Dr Daniel López Serrano of the National Centre for Biotechnology (CNB) and Prof Rubén Martín of the Institute of Chemical Research of Catalonia (ICIQ) have won the XIII Banco Sabadell Award for Biomedical Research and II Banco Sabadell Foundation Award for Science and Engineering, respectively.
Biochemist Dr López Serrano has received the recognition for his innovative contribution in the field of bacterial resistance to antibiotics, a topic which is relevant in terms of biomedicine and sanitation on a global scale.
On the other hand, Prof. Martín has won the award for his innovative and creative vision of chemical ...
23 July 2018
German multinational corporation Hartmann, a CataloniaBio & HealthTech member, will invest €10 million between 2019 and 2021 in its two plants in Mataró and Montornès del Vallès (Barcelona), according to financial newspaper Expansión.
The Mataró factory is a global benchmark in developing and manufacturing adhesive healthcare products and is currently responsible for production of the company’s popular plasters.
In 2017, Hartmann acquired the Lindor brand from Procter & Gamble and saw revenue of €175 million in Spain, up 52% from 2016. The company is open to new acquisitions to continue growing in Spain and expects to see sales of €250 ...
23 July 2018
Over the coming months, the company led by Joan Puig de Dou expects to begin works to expand the laboratories it launched in 2015.
Kymos is a Contract Research Organisation (CRO) that provides R&D and quality-control services for the biopharmaceutical and related industries. Since it was founded in 2001, the company has posted sustained growth. Today, the CRO sees revenue of €10 million and has clients in more than 20 countries ...
21 July 2018
The biomedicine, innovative medical technology and health ecosystem in Catalonia is maturing and there are more and more companies that experience the full business cycle through to success. Licensing deals, selling the company or commercialising the product in different markets are the main paths to this promised land.
Palobiofarma, STAT-Dx and NEOS Surgery are good examples. CataloniaBio & HealthTech invited their founders and general managers to the Lessons Learned debate forum, on 4 July at the Barcelona Science Park (PCB) to share their experiences and the lessons they've learned with new start-ups and spin-offs. The session ...
20 July 2018
ZeClinics, a zebrafish preclinical Contract Research Organisation (CRO) and member of CataloniaBio & HealthTech, has signed a licensing agreement with the Office of Technology Management of the University of California in San Francisco.
With this, the company located at the Barcelona Biomedical Research Park (PRBB) leads licensing and business development efforts on behalf of the university for the commercialization of drug discovery assays in childhood epilepsy by using scn1Lab mutant zebrafish.
We recomend the videointerview to Dr Davide d'Amico, co-founder and CEO of ZeClinics, to learn more about this animal model for preclinical research.
20 July 2018
A cohesive, active and growing ecosystem. These were the words heard most yesterday in informal conversations among the nearly 300 entrepreneurs and professionals from the biomedicine, innovative medical technology and health arena at the CataloniaBio & HealthTech summer networking barbecue (#BBQ2018).
#BBQ2018 was organised for the first time by the new association created just five months ago, through the merger of CataloniaBio and Health Tech Cluster. The event, at the Specipig facilities, demonstrated more than ever the diversity of the start-ups, companies and organisations in the sector in Catalonia. "This diversity, far ...